Lerebours F, Olschwang S, Thuille B, Schmitz A, Fouchet P, Buecher B, Martinet N, Galateau F, Thomas G
INSERM U434-C.E.P.H., Paris, France.
Int J Cancer. 1999 Jun 11;81(6):854-8. doi: 10.1002/(sici)1097-0215(19990611)81:6<854::aid-ijc3>3.0.co;2-1.
Several somatic genetic alterations have been described in non-small-cell lung carcinomas (NSCLC). Recurrent chromosomal deletions have suggested the presence of tumor-suppressor genes specifically involved in lung carcinogenesis. For one of these, 2 non-overlapping regions have been proposed on the short arm of chromosome 8, encompassing the LPL and NEFL genes. The LPL region has been extensively studied in NSCLC and other cancer types. Two genes, N33 and PRLTS, have been identified, but the small number of mutations excludes their involvement in the vast majority of tumors. In order to delineate a reliable region of deletional overlap on chromosome 8p in NSCLC, a series of 77 NSCLC was studied for 34 microsatellite polymorphisms distributed on chromosome 8p, using multiplex-PCR amplification. After purification of tumor nuclei by flow cytometry based on either the abnormal DNA index or the presence of a high expression of cytokeratin, allelic losses on chromosome 8p were observed in 39% of cases. Measurement of DNA index showed that 62% of tumors were hyperploid; allelic losses were more frequent in hyperploid than in diploid tumors (54% vs. 14%; p < 10(-4)). Deletions of part of the short arm were observed in 7 instances. Our data allow definition of an interval of common deletion, flanked by the loci D8S511 and D8S1992, where the putative tumor-suppressor gene might be localized.
非小细胞肺癌(NSCLC)中已发现几种体细胞遗传改变。反复出现的染色体缺失提示存在特别参与肺癌发生的肿瘤抑制基因。其中之一,在8号染色体短臂上已提出2个不重叠区域,包含LPL和NEFL基因。LPL区域已在NSCLC和其他癌症类型中得到广泛研究。已鉴定出两个基因,N33和PRLTS,但由于突变数量少,排除了它们参与绝大多数肿瘤的可能性。为了确定NSCLC中8号染色体短臂上缺失重叠的可靠区域,使用多重PCR扩增,对77例NSCLC研究了分布在8号染色体短臂上的34个微卫星多态性。通过基于异常DNA指数或细胞角蛋白高表达的流式细胞术纯化肿瘤细胞核后,在39%的病例中观察到8号染色体短臂上等位基因缺失。DNA指数测量显示62%的肿瘤为超二倍体;超二倍体肿瘤中等位基因缺失比二倍体肿瘤更常见(54%对14%;p<10^(-4))。在7例中观察到短臂部分缺失。我们的数据允许定义一个常见缺失区间,两侧为位点D8S511和D8S1992,推定的肿瘤抑制基因可能定位在此处。